Attribution of diabetes to the development of severe liver disease in the general population-Reference-Cited by-同舟云学术

Attribution of diabetes to the development of severe liver disease in the general population

Published:2022-05-27 Issue:10 Volume:42 Page:2186-2194
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Vuorinen Miika¹^ORCID,Männistö Ville T.¹^ORCID,Salomaa Veikko²,Britton Annie³,Jula Antti²,Männistö Satu²,Lundqvist Annamari²,Perola Markus²,Åberg Fredrik⁴^ORCID

Affiliation:

1. Departments of Medicine University of Eastern Finland and Kuopio University Hospital Kuopio Finland

2. Finnish Institute for Health and Welfare Helsinki Finland

3. Institute of Epidemiology and Health Care University College London London UK

4. Transplantation and Liver Surgery Clinic Helsinki University Hospital and University of Helsinki Helsinki Finland

Funder

Medicinska Understödsföreningen Liv och Hälsa

Sigrid Juséliuksen Säätiö

Academy of Finland

Sydäntutkimussäätiö

Suomen Lääketieteen Säätiö

Medical Research Council

British Heart Foundation

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15296

Reference35 articles.

1. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. World Health Organization 2.Global health sector strategy on viral hepatitis 2016–2021. Available fromhttp://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1

3. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study

4. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

5. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature and Nurture in Familial Aggregation of Steatotic Liver Disease;Clinical Gastroenterology and Hepatology;2024-04

2. Nonalcoholic fatty liver disease without overlapping metabolic‐associated fatty liver disease and the risk of incident type 2 diabetes;Liver International;2023-06-30